<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Alex Losneanu on Medium]]></title>
        <description><![CDATA[Stories by Alex Losneanu on Medium]]></description>
        <link>https://medium.com/@alosneanu?source=rss-e221691e34b9------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*YAh1V5C2MqeYuMiGbGca-g.jpeg</url>
            <title>Stories by Alex Losneanu on Medium</title>
            <link>https://medium.com/@alosneanu?source=rss-e221691e34b9------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sat, 21 Nov 2026 00:03:30 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@alosneanu/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[The story of eight strides towards increased access to medical oxygen]]></title>
            <link>https://medium.com/better-futures-colab/the-story-of-eight-strides-towards-increased-access-to-medical-oxygen-in-low-resource-settings-39a33a520faf?source=rss-e221691e34b9------2</link>
            <guid isPermaLink="false">https://medium.com/p/39a33a520faf</guid>
            <category><![CDATA[oxygen]]></category>
            <category><![CDATA[product-innovation]]></category>
            <category><![CDATA[world-pneumonia-day]]></category>
            <category><![CDATA[oxygen-as-a-service]]></category>
            <category><![CDATA[oxygen-colab]]></category>
            <dc:creator><![CDATA[Alex Losneanu]]></dc:creator>
            <pubDate>Tue, 12 Nov 2024 10:15:07 GMT</pubDate>
            <atom:updated>2025-01-22T08:51:31.776Z</atom:updated>
            <content:encoded><![CDATA[<h3>The story of eight strides towards increased access to medical oxygen in low-resource settings</h3><p>The story begins against a backdrop of stark inequality. More than 1 million deaths occur every year due to hypoxemia in low- and middle-income countries, many of which could be prevented with appropriate access to medical oxygen. The COVID-19 pandemic laid bare <em>harsh, deep, and deadly inequities</em>, exposing a critical need for systemic changes to address these disparities. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038746/">¹</a></p><p>While the pandemic spurred significant investment in increasing oxygen access within higher-level facilities capable of delivering critical care, this progress left behind lower-level facilities that vulnerable patients rely on as the point of first referral. A peer-reviewed study, which examined oxygen access and usage in secondary-level hospitals in southwest Nigeria <a href="https://academic.oup.com/inthealth/article/12/1/60/5420710?login=false">²</a> , highlighted a crucial insight: improving both access to and effective use of oxygen requires a comprehensive, systemic approach. This approach should not only improve access to affordable equipment but also ensure ongoing availability of consumables like pulse oximeters, spare parts, and critical training and maintenance support.</p><p>In 2020, the UK International Development launched the Oxygen CoLab in response to the urgent need for medical-grade oxygen in low-resource settings, where a lack of access had cost millions of lives. Over the years, the CoLab has evolved into a focused initiative aimed at tackling the systemic challenges of oxygen provision. Through a collective effort, the CoLab and its partners aim to improve availability, affordability, and sustainability in healthcare settings with limited resources.</p><h4><strong>Where we started in 2020: A series of systemic problems in medical oxygen provision for low-resource settings</strong></h4><p>🌍 <strong>Existing oxygen concentrators were not fit for purpose</strong> — in low-resource settings, oxygen concentrators — unsuited to endure dust, heat, and unreliable power — often break down without maintenance, ending up in equipment graveyards.</p><p>📋 <strong>A need for an updated product specification</strong> — the pandemic exposed a need for oxygen concentrator designs that are sustainable, and resilient and can meet the demands of low-resource settings.</p><p>🏢 <strong>Efforts among actors and institutions were siloed</strong> — numerous actors and institutions pursued innovation for oxygen delivery, yet working in isolation limited progress — highlighting the need for coordinated efforts to develop effective, sustainable solutions.</p><p>📉 <strong>A lack of market signals to incentivise manufacturers to invest</strong> — innovators and manufacturers were slow to invest in new oxygen concentrators, held back by weak market signals — without clear demand and support, the drive to innovate remained low.</p><p>💰 <strong>A focus on capital expenses left out crucial maintenance services</strong> — donations and conventional purchasing focused on equipment acquisition, and less so on the enabling conditions that keep equipment working in the longer term.</p><p>❓ <strong>Decision-makers lacked the evidence needed</strong> to understand the role of, and guide the use of concentrators in low-resource settings</p><p>📊 <strong>Governments struggled to prioritise limited funds</strong>, often unable to afford, provide or maintain oxygen infrastructure.</p><p>These challenges impeded the better future that we want to see, a world where preventable deaths due to lack of oxygen are dramatically reduced. By steadily collaborating with others, we have been working towards that future, through experimenting in different parts of the system of oxygen provision, unlocking impact piece by piece.</p><p>Our story so far unfolds as 8 strides made possible through collaboration with our partners and fellow Oxygen CoLabbers, with whom we are building a body of evidence and insights. Our goal is to inform decision-making and drive faster, more effective progress across the sector.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*qyg_tkA90M3vGBclM4MOpA.png" /></figure><h4>1. The CoLab fostered unprecedented collaboration between 100+ (usually siloed) experts in oxygen and defined the better future we want to see</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*M1YwxNPJo1zn8-SGUjGByw.png" /><figcaption>The original networked learning meet-up series</figcaption></figure><p>At the onset of the pandemic, countless talented experts, innovators, and researchers were contributing to oxygen product innovation, yet their efforts remained siloed, with limited coordination across institutions. This lack of collaboration hindered the development of effective solutions for oxygen delivery. Recognising this gap, the Oxygen CoLab brought together over 100 experts from diverse backgrounds — a virtual room filled with doctors from remote clinics, engineers from healthcare startups, policymakers from health ministries, and community health workers from grassroots organisations. Through <a href="https://medium.com/covidaction/the-oxygen-colab-meet-up-on-growth-impact-and-value-aef02d2be58f">six global workshops and networked learning</a> with 20 innovators, we surfaced a long list of evidence gaps, alongside <a href="https://medium.com/covidaction/oxygen-concentrator-workshops-de427c3f3914">solutions for scaling oxygen delivery</a> in fragmented markets. This led to a <a href="https://medium.com/@hollie-59411/increasing-access-to-oxygen-learnings-from-one-year-on-the-oxygen-colab-2b54669c46a6">clear need for both strong business models and human-centred approaches</a>. A key takeaway was the understanding that oxygen concentrators alone aren’t enough; comprehensive systems, including maintenance, training, and user support, are critical to achieving lasting impact <a href="https://medium.com/better-futures-colab/the-oxygen-colab-meet-up-on-growth-impact-and-value-e2f99bcb833b">⁵</a>. From here it was clear we needed to set a course towards a radically better future where everyone whether in an urban hospital, or rural health clinic has access to reliable, consistent medical oxygen.</p><h4>2. There is a <a href="https://www.unicef.org/supply/documents/target-product-profile-oxygen-concentrator">Target Product Profile</a> for oxygen concentrators in low-resource settings</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*mfAx4M1H3czhn5Gnu4yF_g.png" /></figure><p>When the CoLab brought together people already advancing critical work in this field, it created the perfect space to co-design an updated product specification for devices. By collaborating closely with these experts, we captured valuable insights from the network, which directly informed UNICEF’s <a href="https://www.unicef.org/supply/documents/target-product-profile-oxygen-concentrator">Target Product Profile</a> (TPP), shaping a practical guide for development of devices suitable for low resource settings.</p><p>These new specifications were set to challenge manufacturers to think differently, to begin creating devices that could withstand harsh conditions, operate with unreliable power, and be easily maintained by local technicians and biomedical engineers.</p><h4>3. Manufacturers who were not thinking about concentrators for low-resource settings have been building and testing new tech</h4><p>With clear specifications in hand (the Target Product Profile), the next challenge was to create the conditions for manufacturers to invest in reaching the new, higher levels of performance. Many had never considered the unique needs of low-resource settings, nor seen them as compelling market opportunities given the lack of a guaranteed customer base.</p><p>There existed a need to signal manufacturers to invest significant time and resources into innovating new devices that could serve low-resource settings, and persuade decision makers to buy them. By experimenting with both push and pull mechanisms, the CoLab set out to create a compelling case for a new market of oxygen concentrators for use in low resource settings.</p><p>➡️ Pull Mechanism — UNICEF launched a co-creation focused Request For Proposal (RFP) for innovation along with an $8m Advance Purchase Commitment (APC) to de-risk and incentivise the industry. This <em>pull</em> was intended to de-risk the investment for suppliers, ensuring a market for the first products off the line.</p><p>⬅️ Push Mechanism — through funding by UK International Development, the Oxygen CoLab provided Research &amp; Development grants to create a safety net in early prototyping, generate internal buy-in on the manufacturers’ side, and to support innovators to meet accelerated timelines for the APC. This <em>push </em>allowed manufacturers to take bold steps without fear of falling.</p><h4>4. Secured 22:1 co-investment</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*cjklsQ12T7Y3SQ3-" /></figure><p>A catalytic investment of £450,000 from UK International Development sparked a wave of additional funding. This helped to inform UNICEF’s $8million Advance Purchase Commitment of concentrators for low-resource settings. Manufacturers then co-invested their own significant funds in the research &amp; development of their new products in the form of resources and time to develop fit-for-purpose concentrators that met the Target Product Profile. Together this multiplied the initial investment by up to 22 times!</p><h4>5. The first fit-for-purpose oxygen concentrator in the world came to market this year</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/1*Yu2-YNORYVQquAm4kP7tMA.png" /><figcaption>DriveDevilbiss and Sanrai teams showcasing the PulmO2</figcaption></figure><p>One of the UK International Development funded Oxygen CoLab grant recipients, a strategic collaboration between Drive DeVilbiss x Sanrai International, launched the <a href="https://www.sanrai.com/product/oxygen-concentrator-pulmo2/#:~:text=The%20PulmO2%20saves%20up%20to,durability%20especially%20in%20harsher%20environments.">PulmO2</a> earlier this year — the first product to come to market that meets the Target Product Profile. This isn’t just an incremental improvement; it’s a transformative device that promises to be more reliable, energy-efficient, and cost-effective.</p><p>Kröber Medizintechnik’s OxyLink 10 (also funded by the CoLab) and other concentrators are still in development and hope to be ready for user testing and possible final release in the coming years. We hope to see a new crop of fit-for-purpose concentrators emerge from other innovators too very soon.</p><h4>6. The new Drive DeVilbiss PulmO2 concentrator showed transformative results</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/1*aseZ-K-oAI0fA-7Fe-lT0g.png" /></figure><p>The Drive DeVilbiss x Sanrai International <a href="https://pulmo2-concentrator.com/">PulmO2 concentrator</a> showcases what’s possible for low-resource settings. Designed to be solar-friendly, resilient, and easy to maintain, it is specifically built for environments with harsh conditions. The PulmO2:</p><p>🌿 Saves up to 64% of energy compared to traditional models</p><p>🌡️ Withstands extreme conditions like dust, heat, and humidity</p><p>💡 Easily repairable by local technicians, with right-to-repair features</p><p>📋 Includes interoperable manuals and QR codes for quick access to repair videos</p><p>🔔 Offers multilingual labels and maintenance indicators for ease of use</p><p>With these features, the PulmO2 promises to cut operating costs by up to 50%, providing a sustainable, reliable solution for resource-constrained health systems. For healthcare workers, it means peace of mind, knowing they have a dependable tool to save lives that is designed to operate efficiently in challenging environments.</p><h4>7. The Oxygen Concentrator Directory brought market transparency</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Ka6X8_K4UWtJoaBFQw8uyQ.png" /></figure><p>Oxygen equipment designed without considering low-resource environments often lacks durability and clear performance benchmarks, making informed purchasing difficult. The Oxygen CoLab has addressed this gap with the <a href="https://www.makingbetterfutures.org/theoxygenconcentratordirectory">Oxygen Concentrator Directory</a>, produced by <a href="https://home.ecri.org/">ECRI</a>. This resource shares detailed lab testing results of 11 popular oxygen concentrator models assessed in 2023 and 2024.</p><p>By rigorously testing each model against UNICEF’s Target Product Profile, this directory provides decision makers, for the first time, with reliable data on concentrator performance in real-world conditions, supporting better-informed purchasing and providing greater transparency within the medical oxygen ecosystem. Our hope is that this leads to more fit-for-purpose concentrators providing medical oxygen in low resource settings.</p><h4>8. FREO2’s Oxygen-as-a-Service implementation achieved a 71% cost reduction compared to cylinders while maintaining 100% uninterrupted oxygen supply</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*cSF2rH8d1keClbtPq16y1g.jpeg" /></figure><p>Two years ago, whilst working on getting a new fit-for-purpose concentrator in the world, the Oxygen CoLab began to address another systemic barrier reducing access to oxygen in low resource settings — the capacity to maintain and service equipment. Even the best oxygen products and systems need continuous maintenance, training and support to keep running reliably and through conditions such as power outages.</p><p>The CoLab has worked with FREO2 Foundation since 2022 to pilot their Oxygen-as-a-Service model in Tanzania.</p><p>‘<a href="https://medium.com/better-futures-colab/service-based-models-in-oxygen-benefits-analysis-44ac6a3d8cca">Oxygen-as-a-Service’ (O2aaS)</a> describes the approach of using a service-based purchasing model to deliver all steps in oxygen provision from its production, to being at the bedside of a patient who needs it.</p><p>FREO2’s unique O2aaS model, delivered through a technology stack called OxyLink, has achieved a 71% cost reduction compared to oxygen cylinders while maintaining 100% uninterrupted oxygen supply in a trial hospital in Uganda. This was particularly impressive given that the system maintained continuous oxygen flow despite 215 electricity interruptions over a three-month period. This result shows promise for addressing persistent challenges in low-resource settings.</p><p>By embedding essential support features such as power stabilisation, remote monitoring, clinical training, and cost efficiencies, FREO2’s model contributes a holistic framework for rethinking medical oxygen as an accessible utility — similar to electricity or water. This approach could pave the way for more resilient healthcare systems in low resource settings, supporting the wider goal of accessible medical oxygen for all. By addressing the technical, financial, and educational barriers to oxygen access, FREO2 is improving healthcare outcomes in low-resource settings, with a potential to save millions of lives annually.</p><h4>We acknowledge further systemic challenges that need to be tackled next <strong>together with the sector</strong></h4><p>These eight strides reflect the collaborative effort taken to address systemic barriers to medical oxygen access. They wouldn’t have been possible without strategic partners like UNICEF who have complemented our support, manufacturers like Drive DeVilbiss and Kröber, who have pivoted their work to focus on oxygen provision for those with the least access, entrepreneurs like Healthport, FREO2 Foundation, ICChange, Mediquip, Access Oxygen, and Sanrai who continue to advocate for and experiment towards a world where they can provide reliable oxygen through Oxygen-as-a-service models, innovators like CreativeEnergie, Oxygen Alliance, LeanMed, and FREO2 Foundation who are finding ways of creating new devices to enable better oxygen provision. And of course a big community of advisors, activists and supporters such as our amazing <a href="https://www.makingbetterfutures.org/oxyadvisoryboard">Advisory Board</a>, the Oxygen Alliance, the Every Breath Counts Coalition and all its members, as well as the Global Oxygen Alliance.</p><p>But the work is not yet complete, and we are now focusing on addressing systemic issues across two key areas:</p><ol><li><strong>Supply</strong>: A lack of a healthy and competitive market of oxygen suppliers providing services in low-resource settings</li><li><strong>Demand</strong>: Governments need to prioritise their limited funds and often can’t afford to invest in oxygen</li></ol><h4><strong>Supply: </strong><em>How can we work together to create more robust and competitive local oxygen ecosystems by investing in a strong supply?</em></h4><p>For the past years the CoLab has been fortunate to work with an incredible <a href="https://www.makingbetterfutures.org/oxygenasaservice">portfolio of organisations</a> to test Oxygen-as-a-service business models using a mix of equipment including concentrators, small, portable solar-powered oxygen plants (O2 Cubes), and mini PSA plants across different countries and settings.</p><p>Alongside providing grant funding we’re working with these organisations to model their growth, and implement the adaptations needed to optimise their operational and revenue structures in line with their ambitions.</p><p>In practice, we have found that implementing radically new service models in low-resource settings takes time, and many iterations to understand what works in different contexts. We also know that more needs to be done to build the commercial resilience of O2aaS suppliers, so they can keep expanding to serve the facilities where oxygen is needed most.</p><h4><strong>Demand: </strong><em>How can we work together to make oxygen a priority in national health budgets and establish sustainable financing models that ensure long-term access?</em></h4><p>While donations of equipment since COVID-19 have helped, maintaining this equipment requires long-term funding models and new approaches. In October 2024, the Global Oxygen Alliance (GO2AL) set out a <a href="https://globaloxygenalliance.org/news/the-worlds-first-global-oxygen-strategic-framework-and-investment-case-calls-for-us-4-billion-to-expand-access-to-lifesaving-medical-oxygen-in-low-and-middle-income-countries/">Strategic Framework and Investment Case</a> for medical oxygen that called for $4 billion in investment from funders, alongside ongoing financial commitment from governments to close the oxygen access gap.</p><p>So far our approach has focused on building our understanding of what works through funding and supporting O2aaS pilots. Increasingly, we’re also exploring ways to make oxygen a more affordable utility for whole counties and countries. We believe this could be done by supporting governments to integrate O2aaS into national health budgets rather than rely on sporadic donations of equipment and the time and expertise of overworked clinical staff — and it will need to include innovative financing models, capital incentives, and procurement policy enhancements to enable the commercial scale and long-term sustainability of these business models.</p><p>From fostering collaboration to designing fit-for-purpose concentrators and developing sustainable oxygen business models, we are proud of how far we’ve come with our partners and fellow Oxygen CoLabbers towards decreasing preventable deaths due to lack of access to oxygen. In addition, whilst implementing new initiatives across the world, we have also been building a body of evidence (such as an <a href="https://www.makingbetterfutures.org/theoxygenconcentratordirectory">Oxygen Concentrator Directory</a>) to inform decision-making and drive faster, more effective progress across the sector. You can expect much more of this in early 2025, so stay tuned.</p><p>Are you working on similar challenges and we are yet to connect? Get in touch directly by emailing <a href="/service/mailto:oxygen@makingbetterfutures.org">oxygen@makingbetterfutures.org</a></p><p>— — — — — — — — — —</p><p>This project is enabled by UK International Development funding from the UK government.</p><p>To stay up to date with our latest news, be sure to follow us on <a href="https://www.linkedin.com/company/better-futures-colab/">LinkedIn</a>.</p><p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038746/">¹</a> — Mheidly, N., Fares, N. Y., Fares, M. Y., &amp; Fares, J. (2022). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038746/">Emerging Health Disparities during the COVID-19 Pandemic</a>. <em>Avicenna journal of medicine</em>, <em>13</em>(1), 60–64. <a href="https://doi.org/10.1055/s-0042-1759842">https://doi.org/10.1055/s-0042-1759842</a><br>² — Bakare, A. A., Graham, H., Ayede, A. I., Peel, D., Olatinwo, O., Oyewole, O. B., … Falade, A. G. (2020). <a href="https://academic.oup.com/inthealth/article/12/1/60/5420710">Providing oxygen to children and newborns: a multi-faceted technical and clinical assessment of oxygen access and oxygen use in secondary-level hospitals in southwest Nigeria</a>. <em>International Health</em>, <em>12</em>(1), 60–68. doi:10.1093/inthealth/ihz009</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=39a33a520faf" width="1" height="1" alt=""><hr><p><a href="https://medium.com/better-futures-colab/the-story-of-eight-strides-towards-increased-access-to-medical-oxygen-in-low-resource-settings-39a33a520faf">The story of eight strides towards increased access to medical oxygen</a> was originally published in <a href="https://medium.com/better-futures-colab">Better Futures CoLab</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Oxygen CoLab’s next chapter begins]]></title>
            <link>https://medium.com/better-futures-colab/oxygen-colabs-next-chapter-bringing-together-product-development-service-model-innovation-and-fb2eca82c1e?source=rss-e221691e34b9------2</link>
            <guid isPermaLink="false">https://medium.com/p/fb2eca82c1e</guid>
            <category><![CDATA[oxygen-colab]]></category>
            <dc:creator><![CDATA[Alex Losneanu]]></dc:creator>
            <pubDate>Sun, 01 Oct 2023 13:41:15 GMT</pubDate>
            <atom:updated>2023-10-02T09:20:49.280Z</atom:updated>
            <content:encoded><![CDATA[<p>With continued support from the UK’s Foreign Commonwealth and Development Office, the Oxygen CoLab is bringing together product development, service model innovation and advocacy to deliver on the promise of oxygen concentrators in low-resource settings.</p><p>For the next two years we will be collaborating and experimenting to deliver on the promise of oxygen concentrators to expand access to low-resource settings.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*XPVS-h7sFZgIJLxy" /><figcaption><em>Healthport checking Flow Meter installation at Harvey Hospital in Yaba, Nigeria</em></figcaption></figure><p>Since its formation in 2020, the CoLab has been exploring the conundrum of why the potential of oxygen concentrators has yet to be effectively realised in low-resource settings across the world, despite the ongoing work from global partners to implement them and the existing evidence that shows them to be effective and economical sources of oxygen.</p><p>Our work over the past three years has allowed us to both understand the challenges in making oxygen accessible, reliable and affordable for patients at the lower-levels of healthcare; and to begin incubating a set of innovative solutions to these challenges.</p><p>After 100+ conversations with oxygen experts in 2021, we learnt that even if making better oxygen concentrators for lower-and-middle-income-countries was a no-brainer, the challenge was one far from just engineering. It’s not as simple as inventing a new technological solution, because of the <a href="https://hollie-59411.medium.com/increasing-access-to-oxygen-learnings-from-one-year-on-the-oxygen-colab-2b54669c46a6">concurrent ecosystem deficiencies</a>.</p><blockquote>“I’m delighted about the launch of the Oxygen CoLab Phase 2. Together with partners, we hope this next phase of the programme can make a significant impact for patients needing life-saving oxygen in low-resource settings. Oxygen-as-a-service has the potential to provide more affordable, easier to use oxygen provision that is technically and commercially sustainable. Along with the work on oxygen-as-a-service, we have two lines of research and development, which aim to adapt existing Global North products to be fit for low-resource settings, and support the exploration of new and potentially disruptive technologies. This is all within the collaboration that the CoLab fosters in everything it does — and for which we invite all interested parties to engage.”</blockquote><blockquote><strong><em>- </em></strong><em>Phil Outram, Technology and Innovation Advisor, UK’s Foreign, Commonwealth and Development Office, Senior Responsible Officer Oxygen CoLab</em></blockquote><p>Today, to realise the full potential of oxygen concentrators, we are investing in not only improving products for low-resource settings, but also in developing wrap-around service models which keep concentrators working in health facilities, and helping governments and companies adopt these models effectively. Ultimately our aim is to increase access to oxygen for patients in low-resource settings. (To read more about the history of the CoLab take a look at<a href="https://hollie-59411.medium.com/increasing-access-to-oxygen-learnings-from-one-year-on-the-oxygen-colab-2b54669c46a6"> this post.</a>)</p><p>This post marks the beginning of the next stage in the CoLab’s journey, a phase which we are proud and excited to say will be its most ambitious and impactful to date.</p><p>Over the next two years we will be scaling up our ‘learning by doing’ approach in these three ways…</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*RBVBas0kfgB6IDW9CWLqVg.png" /></figure><h3>1. Innovating products for low-resource settings</h3><p>In this next phase we will be investing in technologists and manufacturers to research, develop and lab test oxygen concentrators that are fit-for-purpose in low-resource settings, both now and in the future.</p><p>We are thrilled to be<a href="https://medium.com/better-futures-colab/how-the-next-generation-of-oxygen-concentrators-get-designed-d1337482b3cc"> supporting two manufactures</a> (Drive DeVilbiss and Kröber Medizintechnik) with research and development grants to innovate their products. Their aim is to make them reach<a href="https://www.unicef.org/supply/media/12621/file/TPP-for-Oxygen-Concentrator-April-2022.pdf"> UNICEF’s Target Product Profile (TPP)</a> in time for the <a href="https://www.ungm.org/Public/Notice/207579">Advanced Purchase Commitment</a> led by UNICEF in 2024. We are also soon to invest in early stage product innovators with strong prototypes that are, by design, also fit-for-purpose in low-resource settings.</p><p>To complement our R&amp;D efforts, we will be funding the lab testing of products that could, in the future, be fit-for-purpose in low-resource settings. We will fund a range of products being manufactured across the world including a range of the most promising new ones, to help us understand what manufacturers will need to improve going forward. The insights from this lab testing will be shared across the sector with the aim of advising large donors, global health partners and governments on future purchases of oxygen equipment.</p><p><strong>➡️ Read more about our </strong><a href="https://www.makingbetterfutures.org/oxyproductinnovation"><strong>product innovation here</strong></a><strong>.</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*inRAN1z-v2oQ_DEZ" /><figcaption>FREO2 Team in Karatu, Tanzania</figcaption></figure><h3>2. Oxygen-as-a-Service</h3><p>We know that improving products alone will not increase access to oxygen in low-resource contexts: machines break or may be used incorrectly. Alongside product innovation, we also need to invest in new service models that can help us break the equipment graveyard cycles.</p><p>Through <a href="https://medium.com/better-futures-colab/the-oxygen-concentrator-hypothesis-what-and-how-we-are-learning-to-strengthen-the-position-of-4586f031710e">a portfolio of on-the-ground pilots</a> we are testing Oxygen-as-a-Service models that allow health facilities to pay vendors for oxygen availability and outcomes, not <em>just</em> equipment.</p><p>Oxygen-as-a-Service allows governments and facilities to pay for oxygen as they would electricity or water (i.e. as a reliable utility). The models we are testing aim to reduce the amount of concentrator maintenance needed whilst increasing the capacity of healthcare workers to use them. We hope that this means they are more able to focus on delivering quality healthcare at the right time, to those that need it most.</p><p>The services-based model goes far beyond just the sale of equipment by integrating essential (and currently absent) services such as maintenance, training and technical support. In doing so, this approach overcomes many of the limitations of traditional purchasing (upfront cost, unpredictable expenses, skills gaps, etc) and carries immense potential for closing oxygen access gaps and preventing unnecessary deaths in low resource settings.</p><p>Alongside funding oxygen-as-a-service pilots, we are also supporting them to grow across health centres, regions and countries. Making this happen requires them to have a business model that works and is commercially viable. The Oxygen CoLab is providing hands-on support to give these organisations the best chance possible of continuing to deliver and grow their services beyond the lifecycle of this programme.</p><p><strong>➡️ Read more about </strong><a href="https://www.makingbetterfutures.org/oxygenasaservice"><strong>Oxygen-as-a-Service and our pilots here</strong></a><strong>.</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Yghb8II4OiSS23flg1L_Kw.jpeg" /><figcaption>Concentrator being set up by the Sanrai team in a facility in Uttar Pradesh, India</figcaption></figure><h3>3. Putting evidence into action</h3><p>Even if we have both the pieces above nailed, the route to global impact is more complex than just bottom-up scaling. In order to unlock scale for these organisations, national and global policy makers will need to invest money and attention to the role of oxygen concentrators in LMICs, i.e. validating their use. They will need to buy them, and they need to provide guidelines and policies that will encourage their use at lower levels of healthcare. If not, our organisations won’t get any traction in selling O2aaS in the healthcare settings where they are needed most.</p><p>We will support this primarily by collecting evidence about where and how oxygen concentrators can be used. Our aim is to ensure that governments can access and use this evidence to inform their spending on oxygen infrastructure.</p><p>We also have ambitions to take part in high level global conversations about oxygen roadmaps, being led by the World Health Organisation. These are the plans that many countries have committed to creating in the next few years that will chart their journey to a more equitable and sustainable oxygen ecosystem. We will want to make sure countries know about the potential of concentrators when they develop their oxygen roadmaps.</p><p><strong>➡️ Read more about how we’re putting </strong><a href="https://www.makingbetterfutures.org/oxyevidenceintoaction"><strong>evidence into action here</strong></a><strong>.</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*-4Sk8NLM0Jbo51XM" /><figcaption>ICChange Checking the functioning of the Oxygen Concentrator in Bumanya Healthcare Facility, Uganda</figcaption></figure><h3>Reaching systems change through working with others</h3><p>The Oxygen CoLab has always been just that, a combination of Co (collaboration) and Lab (testing and learning) all of which is not possible without the support of friends, allies, collaborators and more.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*rfPBG4GlsW1JHCJZ" /><figcaption>Access Oxygen at the Diwopa Health Centre</figcaption></figure><p>If you are reading this then it’s likely you are an oxygen innovator yourself, a manufacturer of health products, a policy maker, a health technical expert, an international funder, or an investor in the health technology space.</p><p>We are looking for CoLabbers that can:</p><ul><li>Help our pilots continue to test and scale their services</li><li>Get our evidence out to the right places</li><li>Share about any product innovation we should know about</li><li>Advise us on where and how we achieve our mission</li></ul><p>If any of this resonates with you then please do get in touch with us at oxygen@makingbetterfutures.org.</p><p><em>You can stay abreast of all the news and insights coming out of the CoLab by following us here on Medium (just click the follow button</em><a href="https://medium.com/better-futures-colab"><em> at the top of this page</em></a><em>), or via o</em><a href="https://www.linkedin.com/company/77678811/admin/feed/posts/"><em>ur LinkedIn page</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=fb2eca82c1e" width="1" height="1" alt=""><hr><p><a href="https://medium.com/better-futures-colab/oxygen-colabs-next-chapter-bringing-together-product-development-service-model-innovation-and-fb2eca82c1e">Oxygen CoLab’s next chapter begins</a> was originally published in <a href="https://medium.com/better-futures-colab">Better Futures CoLab</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Announcing the next phase of Oxygen CoLab and Vaccine Data CoLab]]></title>
            <link>https://medium.com/covidaction/announcing-the-next-phase-of-oxygen-colab-and-vaccine-data-colab-bf9e429c7a53?source=rss-e221691e34b9------2</link>
            <guid isPermaLink="false">https://medium.com/p/bf9e429c7a53</guid>
            <dc:creator><![CDATA[Alex Losneanu]]></dc:creator>
            <pubDate>Mon, 12 Sep 2022 14:00:53 GMT</pubDate>
            <atom:updated>2022-09-12T14:02:49.970Z</atom:updated>
            <content:encoded><![CDATA[<p><em>As of August of 2022, the COVIDaction programme has ended. The Oxygen CoLab and Vaccine Data CoLab will both be continuing under the </em><a href="https://www.makingbetterfutures.org/"><em>Better Futures CoLab</em></a><em> platform.</em></p><p>As the world moves its focus from an ‘emergency response’ towards building resilience against future crises, our focus has also had to shift, as we consider the best way to build on the incredible achievements that came out of the COVIDaction programme in the last two years.</p><p>With funding provided by the FCDO, two streams of work that began under this programme, will now move into their next phases as part of the Better Futures CoLab platform.</p><p>The Oxygen and Vaccine Data CoLabs will be delivered by a consortium including Brink and DT Global, and each CoLab will have their own constellation of strategic partners, experts and collaborators.</p><p>There’s more information on the next phase of our work in <a href="https://medium.com/better-futures-colab/launching-the-next-phase-of-oxygen-colab-and-vaccine-data-colab-7127dc72568a">this blog post</a>, and you can follow our journey at the <a href="https://www.makingbetterfutures.org/">Better Futures website</a>, or via <a href="https://twitter.com/futurescolab?lang=en">@FuturesCoLab</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1022/1*xu5Mb5iybPk3SiFvglY3Pw.png" /><figcaption>The new Oxygen CoLab and Vaccine Data CoLab brand identity</figcaption></figure><p>Finally, we would like to say how grateful we are that we had this opportunity to work with some amazing partners, funders, and meet some great friends, and how much we’re looking forward to continuing to work with many of them during this next phase.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=bf9e429c7a53" width="1" height="1" alt=""><hr><p><a href="https://medium.com/covidaction/announcing-the-next-phase-of-oxygen-colab-and-vaccine-data-colab-bf9e429c7a53">Announcing the next phase of Oxygen CoLab and Vaccine Data CoLab</a> was originally published in <a href="https://medium.com/covidaction">COVIDaction</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Launching the next phase of Oxygen CoLab and Vaccine Data CoLab]]></title>
            <link>https://medium.com/better-futures-colab/launching-the-next-phase-of-oxygen-colab-and-vaccine-data-colab-7127dc72568a?source=rss-e221691e34b9------2</link>
            <guid isPermaLink="false">https://medium.com/p/7127dc72568a</guid>
            <category><![CDATA[oxygen-colab]]></category>
            <category><![CDATA[better-futures-colab]]></category>
            <dc:creator><![CDATA[Alex Losneanu]]></dc:creator>
            <pubDate>Mon, 12 Sep 2022 13:35:02 GMT</pubDate>
            <atom:updated>2022-09-12T15:19:18.055Z</atom:updated>
            <content:encoded><![CDATA[<p>In March 2020, the <a href="https://medium.com/covidaction/covidaction-building-a-technology-and-innovation-pipeline-to-support-the-pandemic-response-24d1ec8aeb86">COVIDaction partnership was established</a>. Funded by the Foreign Commonwealth and Development Office (FCDO), the aim of the collective was to build a technology and innovation pipeline to support action related to the COVID-19 pandemic across a number of key thematic areas.</p><p>After the first twelve months, work in two of those thematic areas had crystallised into more wide-reaching projects: Vaccine Data and Oxygen CoLabs.</p><p>To understand and limit the spread of COVID-19, the work within COVIDaction’s data challenge initially focused on providing data for evidence-driven policy decisions for Ministries of Health, National Statistics Offices and others. This evolved as COVID-19 efforts shifted from detection and prevention to vaccine distribution; and in April of 2021 the <a href="https://medium.com/covidaction/data/home">Vaccine Data CoLab</a> was created to support decision-makers in low- and middle-income countries to close data gaps in vaccine rollouts and provide them with the tools required for equitable, transparent, and efficient vaccine delivery.</p><p>At the same time, to make oxygen more universally available, the work pivoted from finding proven, frugal innovations in ventilator design, to understanding how access to medical-grade oxygen in low- and middle-income countries could be improved. Since its inception, the <a href="https://medium.com/covidaction/oxygen/home">Oxygen CoLab</a> has brought together manufacturers, engineers, innovators, hackers and backers to accelerate the development of robust oxygen concentrators in these low-resource settings.</p><h3><strong>Extending the pathway of what’s possible — beyond scaling promising innovations, there is now the potential to scale new systemic approaches for better futures</strong></h3><p>Of course, the pandemic is not over. But as the world shifts its focus from ‘emergency response’ towards building resilience for the future, we also have to shift our areas of focus.</p><p>With funding provided by the FCDO, the Oxygen and Vaccine Data CoLabs are moving into their next phases, building on the advances already made and scaling their ambitions and their scope.</p><p>To better support this next phase, the COVIDaction programme will be retired and the two CoLabs will be hosted by the <a href="https://www.makingbetterfutures.org/">Better Futures CoLab</a><strong> </strong>platform. Oxygen and Vaccine Data CoLabs will be delivered by a consortium including Brink and DT Global, and each CoLab will have their own constellation of strategic partners, experts and collaborators to make change stick.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1022/1*xu5Mb5iybPk3SiFvglY3Pw.png" /></figure><h4><strong>The Oxygen CoLab: From designing fit-for-purpose technologies to hacking the market for oxygen access</strong></h4><p>Since December 2020 the CoLab has focused on innovating oxygen concentrators, which have a high rate of failure in low resource settings.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*H_wLYfIF2u6f2-0L" /><figcaption>Baby receiving oxygen from grantee FRE02’s oxygen concentrator in Tanzania</figcaption></figure><p>As well as bringing together specialists to explore the causes of oxygen concentrator breakdowns and understand the innovations required to solve them, the CoLab has connected innovators and experts to understand how a fit-for-purpose oxygen concentrator could be brought to market.</p><p>Today, innovators are<a href="https://medium.com/covidaction/oxygen-as-a-service-is-saving-young-lives-f855a9221873"> providing life-saving oxygen in Tanzania and India</a> in areas where it was previously unavailable, <a href="https://medium.com/covidaction/breathing-confidence-into-the-value-of-fit-for-purpose-oxygen-concentrators-that-save-lives-in-9d0d6cbb523f">product development has been catalysed </a>on promising oxygen concentrators and the pace of work towards an <a href="https://www.unicef.org/supply/documents/target-product-profile-oxygen-concentrator">industry-validated Target Product Profile (TPP)</a> has been greatly accelerated.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*St57aVR32WPznPSr" /><figcaption>Our grantee, FRE02’s Engineers gathering around their OxyLink oxygen concentrator</figcaption></figure><p>Our next goal is to accelerate sustainable access to fit-for-purpose oxygen concentrators in underserved health centres and hospitals.</p><p>We’re doing this by funding innovators as they develop and test their ideas, catalysing market traction through funding, coaching and in-country advocacy, and supporting a local and global conversation about oxygen provision by convening and hosting networks of experts across the sector.</p><p><em>Read more about the next phase of the Oxygen CoLab’s work </em><a href="https://www.makingbetterfutures.org/oxygencolab"><em>here</em></a><em>.</em></p><h4><strong>Vaccine Data CoLab: From unshackling the data to using it to create rich insights</strong></h4><p>When it comes to stimulating vaccine demand in under-immunised and vulnerable communities, reliable and real-time data can have a huge impact. The <a href="https://medium.com/covidaction/data/home">Vaccine Data CoLab</a> was established to make hyperlocal data accessible so that on-the-ground decisions on improving vaccine uptake could be made quickly and with confidence.</p><p>Over the past year the CoLab has built crucial bridges between countries’ data needs, existing data systems and appropriate technologies, to create what we call ‘precision public health’.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/700/0*M5mV2zryC5UCX7nS" /><figcaption>Child being vaccinated</figcaption></figure><p>We have convened global vaccine research and data partners to avoid costly duplication of effort, turned research into action on the ground across 18 countries, supported governments and local partners in the use of geographic information systems, developed data dashboards for use in designing better real-time interventions, and co-designed and developed <a href="https://medium.com/covidaction/dissemination-workshop-path-collaborates-with-vietnam-moh-to-internationalise-vietnams-covid-19-a1c47aeb26b9">COVID-19 digital vaccination certificates</a>.</p><p>Now, as the pandemic enters a new stage, our challenge has shifted to how hyperlocal data can be applied to generate demand in under vaccinated populations so that targeted vaccine delivery and behaviour change programmes can be designed.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/512/0*FoJP3k5Aj4a8E2B8" /><figcaption>Geospatial analysis dashboard in Nigeria for vaccine hesitancy by grantee Fraym</figcaption></figure><p>To do this, we’re running in-depth, data-driven experiments in regions with low vaccine uptake to understand vaccine hesitancy and address issues such as matching of vaccine supply and demand as well as insights and impact tracking. In parallel we’re providing support for the <a href="https://www.unilever.com/news/hygiene-behaviour-change-coalition/">Hygiene &amp; Behaviour Change Coalition</a> (HBCC2) and FCDO’s C-19 Behaviour Change Forum across 18 countries in Africa and Asia.</p><p><em>Find out more about the Vaccine Data CoLab </em><a href="https://www.makingbetterfutures.org/vaccinedatacolab"><em>here</em></a><em>.</em></p><p><em>Get in touch with us if you’d like to know more about our CoLabs or you’d like to become involved: hello@makingbetterfutures.org</em></p><p><em>For regular updates on our work follow Better Futures CoLab on Twitter: </em><a href="http://twitter.com/futurescolab"><em>@FuturesCoLab</em></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=7127dc72568a" width="1" height="1" alt=""><hr><p><a href="https://medium.com/better-futures-colab/launching-the-next-phase-of-oxygen-colab-and-vaccine-data-colab-7127dc72568a">Launching the next phase of Oxygen CoLab and Vaccine Data CoLab</a> was originally published in <a href="https://medium.com/better-futures-colab">Better Futures CoLab</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[From freeze to finish]]></title>
            <link>https://medium.com/hellobrink-co/from-freeze-to-finish-73e4e8c588d3?source=rss-e221691e34b9------2</link>
            <guid isPermaLink="false">https://medium.com/p/73e4e8c588d3</guid>
            <category><![CDATA[covid19]]></category>
            <category><![CDATA[tech-for-good]]></category>
            <category><![CDATA[behavioural-innovation]]></category>
            <category><![CDATA[innovation]]></category>
            <category><![CDATA[tech-trends]]></category>
            <dc:creator><![CDATA[Alex Losneanu]]></dc:creator>
            <pubDate>Tue, 07 Dec 2021 09:30:07 GMT</pubDate>
            <atom:updated>2021-12-07T21:37:44.513Z</atom:updated>
            <content:encoded><![CDATA[<h4>The 5 principles which helped us build a tech and innovation pipeline during a global pandemic</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/700/0*pP1wCjfvF9VADGwG" /><figcaption><strong><em>Global Auto Systems </em></strong>team members <a href="https://medium.com/covidaction/addressing-covid-19s-multiple-challenges-with-technological-innovation-in-uganda-c1b10d89a7c">making face shields in Uganda</a></figcaption></figure><p>Do you remember how you felt in March 2020 — the month the UK went into a national lockdown? The month when the words “global pandemic” really hit home?</p><p>I do. I remember being struck by an overwhelming sense of panic.</p><p>But I was also incredibly lucky to be part of a team funded by UK Aid who within 24 hours of the WHO’s announcement of a global pandemic, launched <a href="https://medium.com/covidaction/what-is-covidaction-2605efa4803a">COVIDaction</a>: an initiative to source and scale innovations from across the globe responding to the pandemic. By offering funding and venture support to make them happen, we brought together a team of multidisciplinary experts who hoped to uncover the next generation of innovations to solve the pandemic and other global challenges across four thematic areas: local production and solutions, data, resilient health systems, and global access to oxygen.</p><p>I’ve learned very soon after the launch that innovation often lies on the side of discomfort — in the midst of ambiguity, uncertainty, tension and risk. This was the first time we set out to do this type of work with our wonderful partners (<em>Results for Development, IMC Worldwide, Global Disability Innovation Hub, UCL’s Institute of Healthcare Engineering)</em>, whilst moving to work from home, dealing with health and family concerns. Everyone had questions and all I craved was answers.</p><p>In this type of uncertain situation, ideally I should have been at my most adaptive, but instead, I froze. My body entered survival mode, my mind paralysed by the uncertainty of what lay ahead. This was a significant departure from my usual energetic-getting-things-done self.</p><p>Something physical happens when we’re stressed. When triggered by threats, blood is pulled away from the logical, rational part of our brain (known as the prefrontal cortex) towards our limbic system. This is the oldest, reptilian part of our brain, which is trying to keep us safe by telling us what we need to do next: fight, flight or freeze. This is why it can be difficult to make good decisions during times of uncertainty — our brain simply doesn’t like it. It’s safe to say that at the beginning of COVIDaction I was caught in a ‘limbic freeze’. But at Brink, we’re intentional in <a href="https://medium.com/learnadapt/managing-uncertainty-when-your-brain-doesnt-like-it-9f220ffe1252">managing uncertainty</a> so that we can thaw out of that freeze and pull together with our brilliant partners and funders.</p><h4><strong>💨 Fast-forward 20 months later</strong></h4><p>FCDO-funded COVIDaction has invested £2.4 million of grant funding into 36 innovations, each contributing to remarkable responses to the pandemic, from using banana tree trunk fibre for producing safe birthing kits to new healthcare models in Bangladesh and global epidemiological data models.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*zVrEvs5ZCwCKEHqpVqzcuQ.jpeg" /><figcaption>COVIDaction innovators</figcaption></figure><p>We have also prototyped new global models of collaboration, convening product innovators, academics and engineers to <a href="https://medium.com/covidaction/how-can-we-get-fit-for-purpose-oxygen-concentrators-to-low-resource-settings-95da16c71443">clear the path to market for essential products like oxygen concentrators,</a> and the public sector to pave the way with regulation and financing. We’ve also designed inclusive models for surfacing innovation, working with local organisations to <a href="https://medium.com/covidaction/connecting-the-unconnected-covidaction-capacity-building-support-for-offline-communities-in-africa-9fbeccd6f124?source=collection_category---4------0-----------------------">surface offline communities of local grassroots producers</a>, to engage with those who were not connected to the internet.</p><h4><strong>Our approach allowed us to step into the unknown. And I want to share with you the five principles which underpinned it:</strong></h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/932/1*Cl9zAoZCjBB3-ARwLIIVOg.png" /></figure><h3>1. A moral purpose anchors you.</h3><p>We acknowledged early on that you can’t always be in control of everything. But you can always ground yourself in <em>why</em> you are doing something. During COVIDaction, this boiled down to the project’s moral purpose.</p><p>COVIDaction was created to explore how the pandemic might become the driving force for long-term resilience and the role of technology in this change.</p><p>Everyone could see the long-term impact of this project. It touched the greener recovery, strengthened health systems, access to oxygen, informed decision making. This was our anchor for the duration of the project and acted as our guiding principle behind all our strategies and investments.</p><p>We cared deeply about constantly having a shared way forward and iterated our direction as new priorities emerged from the pandemic (more on this below).</p><h3>2. Focus on questions over answers.</h3><p>At Brink we don’t seek answers, we ask questions — as there’s always more to learn.</p><p>This is because we’ve found that questions open up a world of possibilities and stimulate curiosity, imagination, aligning everyone to the same big goal. Meanwhile, answers often only have temporary value, as they may only be correct under particular circumstances.</p><p><strong>During COVIDaction we asked:</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/847/0*FOrxw0ZMYgoru4Qi" /></figure><p>Every two months we paused to take stock. We asked ourselves ‘what have we learned?’ and ‘are these still the right questions to ask?’ instead of ‘have we found the answer to these big questions?’</p><p>For some questions, certainty may never be reached and that’s OK.</p><h3>3. It’s all about the networks.</h3><p>Finding solutions to some of the biggest questions of our time, like global access to oxygen or the equitable distribution of vaccines, requires collaboration.</p><p>During COVIDaction we recognised this work is bigger than us and that to create change we would need to build networks and connect with the wider ecosystem, to pool our collective knowledge and resources.</p><p>This looks like:</p><ul><li>Applying networked learning to inform the next generation of oxygen concentrators for low-resource settings, engaging with 100+ experts through a <a href="https://medium.com/covidaction/the-oxygen-colab-meet-up-on-growth-impact-and-value-aef02d2be58f">global series of meetups and interviews;</a></li><li>Supporting our innovator from Nepal to build a <a href="https://makerko.com/">web of production</a> to have better insight into existing PPE demand and production capacity;</li><li><a href="https://afrilabs.com/afrilabs-and-covidaction-to-support-offline-community-ventures-in-kenya-nigeria-and-uganda/">Bringing together communities of local producers</a> not connected to the internet to learn from each other.</li></ul><p>We’ve learned together with our networks and explored those big questions. And this has made the journey much more enjoyable and helped bring clarity.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FJ4zYvG8hT7I%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DJ4zYvG8hT7I&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FJ4zYvG8hT7I%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/7f6fb9e09b770f78dcadd2557266b1de/href">https://medium.com/media/7f6fb9e09b770f78dcadd2557266b1de/href</a></iframe><h3><em>4. </em>Really listen.</h3><p>We’ve built the networks, but then we also listened closely to what was emerging from the work of our partners and collaborators. We then moved resources around based on their feedback and requests for support. For example, many of our <a href="https://medium.com/covidaction/building-a-healthy-data-ecosystem-to-fight-covid-19-or-doingdataright-ed0305bd1313?source=collection_category---4------1-----------------------">data innovators</a> pivoted to respond to the emerging needs of the pandemic, such as the equitable distribution of vaccines. We’ve followed them on their journey, and changed our focus to exploring <a href="https://medium.com/covidaction/apply-now-open-call-announcement-of-the-vaccine-data-co-lab-6f0a4e367066">how data might be used for the equitable distribution of vaccines?</a></p><p>You can’t learn if you don’t listen. When it comes to creating positive change, if feedback isn’t genuinely listened to and incorporated into your strategy you’ll simply miss out on driving meaningful change.</p><h3>5. Frameworks provide autonomy.</h3><p>Establishing a process across multiple environments doesn’t work if it’s enforced rigidly. Yes it can provide a good outline of how to get from ‘A’ to ‘B’, but there always needs to be flexibility in place, as no situation or team is the same. People and organisations need to be given their own autonomy and sense of independence, so they feel empowered to not only do the job well, but make suggestions on how it can be improved.</p><p>During COVIDaction Brink created an intentional simple framework to give us the handrails to help us answer those big questions. We called it <a href="https://medium.com/covidaction/covidaction-building-a-technology-and-innovation-pipeline-to-support-the-pandemic-response-24d1ec8aeb86">SETS</a>. We set out to <strong>S</strong>can the globe for promising innovation, <strong>E</strong>valuate what we find, <strong>T</strong>eam up with experts for venture support, and<strong> S</strong>hare what we find as a global good. We’ve brought world-class experts to lead each area, but made sure to use the SETS framework as a guide, not dogma, with space to dial elements up or down depending on what experts believed was suited to each — vastly different — area.</p><p>We didn’t make the calls, we just provided a framework for the big questions shared above to be answered.</p><h3>The beauty about this model is that once you set it up, it will continue to have a life of its own.</h3><p>Once the entire team embodied this framework, it helped us ensure our networks could also leverage it to continue to answer our shared big questions, beyond our direct support. For example, we partnered with pan-African organisation <a href="https://afrilabs.com/afrilabs-and-covidaction-to-support-offline-community-ventures-in-kenya-nigeria-and-uganda/">AfriLabs</a> to lead <a href="https://medium.com/covidaction/get-your-feet-on-the-ground-insights-from-scouting-local-innovations-47ae7eb39f0f?source=collection_category---4------2-----------------------">a local innovation scouting</a> process. We wanted to explore together the <strong>big question</strong> <a href="https://medium.com/covidaction/afrilabs-scouts-engage-grassroots-communities-for-impact-in-africa-e5472bb96e70?source=collection_category---4------4-----------------------">‘How do you connect global resources to local communities to support recovery in a time of crisis?’</a></p><p>AfriLabs went on and activated their own <strong>network</strong> across 3 African cities to help scout local innovation, <strong>listened</strong> to the constraints of their network when engaging with these communities, and <strong>set up a framework</strong> through which their networks were able to deliver direct support to these innovators. And the virtuous circle continued with their networks taking on this big question, making it theirs, tapping into their own networks and so on.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/673/0*ibB7KIHrKdX6CVia" /></figure><p>In March 2020, we had no idea what would emerge through our open calls for innovation and if we would even take up a role in the global response to the COVID-19.</p><p>Even though today we know so much more than last year, we are still innovating in a space of deep uncertainty. But we now know that our 5 practices will have our back! And that they will also support our networks (and their networks) to work and learn together about the potential of technology in the long-term response to the pandemic crisis.</p><p>This exploration of the unknown would have simply not existed if it were not for our visionary FCDO colleagues who trusted us and had our back through the many iterations of this work as new information became available during the pandemic. These practices essentially emerged through the strategic brains of Magdalena Banasiak, Lea Simpson and Tamara Giltsoff coming together on those dark March 2020 Thursday mornings. And they have the fingerprints of all the wonderful theme leads, team members and partners all over them.</p><p><strong>To find out more about </strong><a href="https://twitter.com/COVIDactionTech"><strong>COVIDaction</strong></a><strong>, follow them on </strong><a href="https://twitter.com/COVIDactionTech"><strong>Twitter</strong></a><strong> or read their </strong><a href="https://medium.com/covidaction/explainer/home"><strong>blog</strong></a><strong>.</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*mpKNA0jbqr03J_4Z.jpeg" /><figcaption><a href="https://medium.com/covidaction/ending-maternal-mortality-zambian-activist-chronicles-her-story-to-support-vulnerable-women-during-7f5759aee7f9"><em>Safe Motherhood Alliance</em></a><em>, a social enterprise improving safe births by developing life-saving baby delivery kits and other services for pregnant mothers.</em></figcaption></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=73e4e8c588d3" width="1" height="1" alt=""><hr><p><a href="https://medium.com/hellobrink-co/from-freeze-to-finish-73e4e8c588d3">From freeze to finish</a> was originally published in <a href="https://medium.com/hellobrink-co">Brink blog</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[What is COVIDaction?]]></title>
            <link>https://medium.com/covidaction/what-is-covidaction-2605efa4803a?source=rss-e221691e34b9------2</link>
            <guid isPermaLink="false">https://medium.com/p/2605efa4803a</guid>
            <category><![CDATA[covid19]]></category>
            <category><![CDATA[technology]]></category>
            <category><![CDATA[covidaction]]></category>
            <category><![CDATA[covid-response]]></category>
            <dc:creator><![CDATA[Alex Losneanu]]></dc:creator>
            <pubDate>Sun, 14 Mar 2021 15:22:54 GMT</pubDate>
            <atom:updated>2021-08-02T10:36:27.647Z</atom:updated>
            <content:encoded><![CDATA[<p><em>*Your quick start guide to the programme*</em></p><p><strong><em>How have pivots in local production and novel approaches met local needs?</em></strong></p><p><strong><em>What is the role of technology in building resilient health systems?</em></strong></p><p><strong><em>What are the best tools for using data to inform decision-making?</em></strong></p><p><strong><em>How can we get fit-for-purpose oxygen concentrators to low-resource settings?</em></strong></p><p>In March 2020 we <a href="https://medium.com/covidaction/covidaction-building-a-technology-and-innovation-pipeline-to-support-the-pandemic-response-24d1ec8aeb86">set out on a path</a> to answer big questions like the ones above and uncover the roles that technology can play in the response to COVID-19. Since then we have launched four themes,<a href="https://medium.com/covidaction/what-is-covidaction-local-production-local-solutions-3f12d86b9ed3"> Local Production &amp; Local Solutions</a>, <a href="https://medium.com/covidaction/building-a-healthy-data-ecosystem-to-fight-covid-19-or-doingdataright-ed0305bd1313">Data</a>, <a href="https://medium.com/covidaction/what-is-covidaction-resilient-health-systems-979ce6c0046f">Resilient Health Systems </a>and <a href="https://medium.com/covidaction/how-can-we-get-fit-for-purpose-oxygen-concentrators-to-low-resource-settings-95da16c71443?source=collection_category---2------0-----------------------">The Oxygen CoLab</a> to find answers and support the innovations that help low and middle income (LMICs) countries make decisions and face the pandemic.</p><p>COVIDaction is a programme funded by UK Aid, that is building a technology and innovation pipeline to support the pandemic response and recovery — this means we scan the globe for promising innovation, rigorously evaluate COVID-19 pivots and solutions and work on sensemaking and sharing what we have learned. As a result, we work toward encouraging the very best ideas with grant funding and venture building support and share what we learn as a global good.</p><p>The programme is a partnership between the Foreign, Commonwealth and Development Office’s Frontier Technology Hub, Global Disability Innovation Hub (GDI Hub), UCL’s Institute of Healthcare Engineering along with other collaborators.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*j5-UNJWLSg82zENs" /></figure><h3><strong>Four thematic areas</strong></h3><p>Working in agile and emergent ways, we have identified four thematic areas, informed by conversations with entrepreneurs, experts and innovators within the Africa tech ecosystems, FCDO/UK gov and actors operating on the ground. We are always open to fresh areas where we can bring an impact. Here’s a little about each theme:</p><p><a href="https://medium.com/covidaction/what-is-covidaction-local-production-local-solutions-3f12d86b9ed3"><strong>Local Production Local Solutions</strong></a> — This theme addresses the need for shorter supply chains, mapping and crowdsourcing remarkable pivots and responses that deal with scarcity of goods. It highlights circular economy and distributed manufacturing as two emergent approaches to more resilient production.</p><p><a href="https://medium.com/covidaction/building-a-healthy-data-ecosystem-to-fight-covid-19-or-doingdataright-ed0305bd1313"><strong>Data</strong></a> — This thematic area explores the latest and best data tools that inform decision making. Data is vital in the response to the pandemic and the team investigates how it can be used efficiently, responsibly and where analysis can take us.</p><p><a href="https://medium.com/covidaction/what-is-covidaction-resilient-health-systems-979ce6c0046f?source=collection_category---2------0-----------------------"><strong>Resilient Health Systems</strong></a> — Here we focus on the role that technology and innovation can have in supporting countries to build and maintain resilient health systems. COVID-19 is having a massive impact on health systems, but regular health support is also vital for everyone and must be supported.</p><p><a href="https://medium.com/covidaction/how-can-we-get-fit-for-purpose-oxygen-concentrators-to-low-resource-settings-95da16c71443?source=collection_category---2------0-----------------------"><strong>The Oxygen CoLab</strong></a> — Oxygen is critical for the treatment of COVID-19. This theme is working to map supplies, spot bottlenecks and explore the creation of oxygen concentrators to ease supply issues in low and middle income countries.</p><h3><strong>A blended package of support</strong></h3><p>Through our work it became clear that giving money to organisations working to respond to the pandemic was not enough. We set out to support the most promising ideas with a blended package of funding and non-financial support in the form of technical assistance with top class experts, peer-to-peer learning and connections to other investors and donors.</p><p>Non-financial support has no price-tag but it can be of huge value to growing innovation. We listen carefully to our grantees so we can connect them with the guidance they are asking for and truly need at a time when scaling, production and moving forward are vital.</p><h3><strong>🏆 Our investments: from clay pots to epidemiological models</strong></h3><p>We have built strong portfolios of investments across all thematic areas, investing in 30 remarkable innovations that support action related to the pandemic — from ancient clay pots converted into hand washing facilities in South Sudan, to established organisations forming new consortia to democratise healthcare in Kenya, and global epidemiological models from leading institutions. <em>(Follow the links for each theme above for a deep dive into each portfolio).</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*tkCHpGykOntIVEn2" /></figure><h3><strong>What’s next for COVIDaction?</strong></h3><p>The past year has been intentionally emergent for the COVIDaction team. So far we have invested in exciting portfolios across the majority of our themes, and had the privilege to work with incredible innovators and partners across Africa and South Asia. Now that we have brought great minds together for the immediate response to C-19, our collective thinking is being shaped by <a href="https://medium.com/covidaction/20-things-we-learned-this-year-that-could-be-signals-of-what-comes-next-c07e123c1582?source=collection_category---2------0-----------------------">signals </a>we’re seeing of how the pandemic might serve as an inflection point for tech-enabled, longer-term resilience in LMICs. We’re seeing governments across the world striving to ‘build back better’, which is becoming one of the biggest and most wicked challenges of our time, the new ‘going to the moon’, if you like<em> (reminding us of Prof. Mariana Mazuccato’s </em><a href="https://marianamazzucato.com/research/policy-papers#paper-23"><em>mission-oriented innovation)</em></a>. Building more resilient future systems will require cross-sectoral and global collaboration, boldness, experimentation.</p><p>For our next phase, we will work with ambitious partners across the globe towards futures where long-term resilience is enabled by technology, and where…</p><ul><li>access to local products and services is increased</li><li>vaccines are distributed equitably</li><li>vulnerable populations have access to oxygen</li><li>health is democratised</li></ul><p>We’re inviting anyone who has the same missions to get in touch — drop us a line here: <a href="/service/mailto:COVIDaction@hellobrink.co">COVIDaction@hellobrink.co</a>.</p><h3><strong>Keep in touch!</strong></h3><p>We will continue to share what we learn along the way, so watch this space for more information, subscribe to our COVIDaction Friday Download <a href="https://covidaction.substack.com/">newsletter</a>, and if you are on Twitter, follow <a href="https://twitter.com/COVIDactionTech">@COVIDactionTech</a>.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=2605efa4803a" width="1" height="1" alt=""><hr><p><a href="https://medium.com/covidaction/what-is-covidaction-2605efa4803a">What is COVIDaction?</a> was originally published in <a href="https://medium.com/covidaction">COVIDaction</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[20 things we learned this year — that could be signals of what comes next]]></title>
            <link>https://medium.com/covidaction/20-things-we-learned-this-year-that-could-be-signals-of-what-comes-next-c07e123c1582?source=rss-e221691e34b9------2</link>
            <guid isPermaLink="false">https://medium.com/p/c07e123c1582</guid>
            <dc:creator><![CDATA[Alex Losneanu]]></dc:creator>
            <pubDate>Fri, 18 Dec 2020 11:42:26 GMT</pubDate>
            <atom:updated>2020-12-18T12:21:39.695Z</atom:updated>
            <content:encoded><![CDATA[<h3><strong><em>20 things we learned this year — that could be signals of what comes next</em></strong></h3><h3><strong><em>Predicting the future may be best left to seers and magicians, but what we can do is apply what we know now to the year ahead as they change the way we will work. We’re pleased to share our future gazing with you in the hope that there might be something simple in here that can help anyone in our sector.</em></strong></h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*0NKKnF0g7-EsUJz30dyTVw.png" /></figure><p>When we launched COVIDaction, we asked the question: <a href="https://medium.com/covidaction/covidaction-building-a-technology-and-innovation-pipeline-to-support-the-pandemic-response-24d1ec8aeb86">How can we build a technology and innovation pipeline to help the response to the pandemic?</a> This was back in March (can you believe it was only March?). We started our work with a search for frugal innovation around ventilators and from this emerged three themes — <a href="https://medium.com/covidaction/local/home">Local Production &amp; Local Solutions</a> — to address the need for shorter supply chains and innovation at ground roots, <a href="https://medium.com/covidaction/data/home">Data</a> — to explore the the best data tools to inform decision making, and <a href="https://medium.com/covidaction/resilient-health/home">Resilient Health Systems</a> — to explore the role of technology and innovation in supporting countries to build resilient health systems as they respond to the COVID-19 crisis.</p><p>In December we launched a new theme — <a href="https://medium.com/covidaction/how-can-we-get-fit-for-purpose-oxygen-concentrators-to-low-resource-settings-95da16c71443">The Oxygen CoLab</a> — to map oxygen supplies, spot bottlenecks and explore the creation of oxygen concentrators to ease the supply in low and middle income countries.</p><p>As you can imagine, work has been fast and curious. We have made connections, seen patterns emerge and worked in flexible ways to continue questioning and searching for answers. Here are the signals we’ve picked up this year that help us imagine the future.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*INz5Qw28s591QYSEJUKW2A.png" /></figure><h3><a href="https://medium.com/covidaction/local/home"><strong>Local Production &amp; Solutions</strong></a></h3><p><strong>1.Flexibility is the key to resilient production. </strong>Processes that calcify a venture or system’s ability to shift its behaviour in response to new problems or opportunities reduce its ability to survive in a dynamic environment. Flexibility can be achieved in two ways though — internally, with production capacity that is adaptable, or through collaborative manufacturing with other producers.</p><p><strong>2. COVID-19 could be the driving force to address humanity’s bigger challenges. </strong>The pandemic has been catastrophic, but it pales in comparison to the climate crisis and global inequality. Humanity’s response is bringing us chances to make big strides towards greener manufacturing and democratised marketplaces. We need to keep our eyes on the prize though.</p><p><strong>3. Localised value chains can be more resilient, more environmentally friendly, and serve consumers better. </strong>They are not at the whim of untrustworthy global supply chains and profit can build local capacity and additional services rather than go straight back to the top of a pyramid. Building locally means the ability to listen and adapt to what resident consumers actually want, rather than decide for them.</p><p><strong>4. Waste is the worst thing humans have ever invented. </strong>We need to strike it from our memories. Innovators have woken up to the value in the resources left over from other production processes and found ways to incorporate them into other products. Systems to identify and nurture this resource use are always beneficial.</p><p><strong>5. Local context and knowledge is crucial.</strong> Before you can try to solve local problems you need to forget what you know before you ‘arrive’. Many of the innovations we have found are being enforced and championed by a single person. Once we engage with these social entrepreneurs, we find that they have an intimate and detailed knowledge of local contexts, cultures and issues. It is this ‘on the ground’ connection and passion that drives the changing force and is part of the reason we have shown interest in their value.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*JBmmFMnFMQLWSaaarYf-1Q.png" /></figure><h3><a href="https://medium.com/covidaction/resilient-health/home"><strong>Resilient Health Systems</strong></a></h3><p><strong>6. Innovators learn by doing.</strong> It sounds simple, but these are the people who go out there and just see if it works. In our sector, people like to write and read papers — they prefer to take it slow. Innovators are folks who have the mindset that they will give it a shot and adapt as they go. Our RHS grantees are piloting <a href="https://medium.com/covidaction/announcing-the-resilient-health-systems-awards-1c95f2be0fb1">telemedicine, mHealth, and data </a>innovations and tweaking nimbly as they scale to ensure that their work is successful.</p><p><strong>7. Health systems are complex…and so are their users.</strong> Mixed health systems solutions only work if the community trusts the system. That means they need to meet users where they are. When integrated into health systems, technologies that are focused on end users — innovations such as <a href="https://www.youtube.com/watch?v=xWQQW1AcXHY">Wheels for Life</a> and <a href="https://www.pensa.org.mz/">Pensa</a> — can help to reach underserved communities and build confidence in the wider health system. Others, such as the <a href="https://www.nytimes.com/2020/10/13/health/coronavirus-vaccine-hesitancy-larson.html?action=click&amp;module=Top%20Stories&amp;pgtype=Homepage">Vaccine Confidence Project</a>, help system stakeholders use data to identify issues with confidence and trust, and take action to improve.</p><p><strong>8. Necessity remains the mother of invention.</strong> COVID-19 has been an action-forcing mechanism for health systems strengthening. While the pandemic has revealed significant challenges with essential service delivery during a crisis, innovators can help systems to adapt. A great example of this is the ability to shift the locus of care from facilities to homes and communities through telehealth innovations such as <a href="https://mytonic.com/en/about-tonic">Digital Hospital (formerly TONIC)</a> and <a href="https://www.mymdoc.com/">mDoc</a>. Adaptation is a hallmark of resilience: changes today will outlive the virus, and help us to better respond to the next shock.</p><p><strong>9. Learning requires trust.</strong> Innovation teams and their coaches work best when mutual trust enables a learning environment where it is safe to fail. In response to our resilient health systems challenge, we’ve spotted different organisations coming together to form new consortia with even stronger applications. Our nine grantees know of each other already and so there is a foundation of credibility and trust on which they can build a peer learning network.</p><p><strong>10. Teamwork is hard, but necessary.</strong> Our consortium partners are so different, but we need each team’s super powers to achieve the ambitious goals we set. RHS engaged a minimum of 300 expert hours (and likely much longer) into the first two evaluation rounds with 36 health and innovation expert reviewers and 11 FCDO regional expert reviewers committed to the task. It really does take a village!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*CMz-GqV1WMkn7Svmo-uLtA.png" /></figure><h3><a href="https://medium.com/covidaction/data/home"><strong>Data</strong></a></h3><p><strong>11. Data use is crucial.</strong> It means meeting people where they are and embedding data tools into existing workflows and processes. Working with <a href="https://www.data4sdgs.org/">GPSDD</a>, the Data Challenge team is bringing data tools to decision makers working on a response to COVID-19. This includes overlap with other data tools and platforms funded by FCDO, like the <a href="https://grid3.org/">GRID3</a> data hubs in countries like Nigeria and Sierra Leone.</p><p><strong>12. Communicating complex tools takes time.</strong> Gaining buy-in for the use of new technology takes time. It’s why we prioritised mature offerings with an existing user base and built-in capacity. Even with these advantages, getting users to adopt new tools is hard. As an example, one of our grantees, <a href="https://www.openfn.org/about">OpenFN</a>, has been working with a Ministry of Health to address a data interoperability problem for the past 6 months.</p><p><strong>13. Data tools can pivot, fast.</strong> Our grantees have bolted on new COVID-19 data tools to existing platforms and gone to scale, fast! BAO Systems, for example, debuted a COVID-19 Surveillance Package in countries around the world, and has been evaluated as a leading digital solution for COVID-19 response by <a href="https://www.dhis2.org/covid-jhu-report">Johns Hopkins University</a>, the <a href="https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/compare-digital-tools.html">CDC</a>, and <a href="https://digitalsquare.org/covid19">Digital Square</a>.</p><p><strong>14. Responsible data is crucial for digital tool use</strong>. In emergency contexts it’s often tempting to play fast and loose with responsible data considerations, things like privacy and security can take a back seat to response in the moment. That’s why COVIDaction is investing in programmes which help actors quickly address these concerns (to make it easier to do the right thing) and in grassroots initiatives that are pushing for improved data use.</p><p><strong>15. Show don’t tell</strong>. Good data visualisation is key to uptake and use of digital tools. Data by itself doesn’t drive change, it needs to be structured and presented in a way that can drive data use (see point 1, above!). Grantees like Surgo Ventures (Foundation) have delivered <a href="https://precisionforcovid.org/africa">tools that do just this</a>, providing a platform for end users to better understand and apply data tools for their specific context.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*rhwa02WlNA1Sq-oG3BHveQ.png" /></figure><h3><a href="https://medium.com/covidaction/how-can-we-get-fit-for-purpose-oxygen-concentrators-to-low-resource-settings-95da16c71443"><strong>The Oxygen CoLab</strong></a></h3><p><strong>16. Systemic problems call for systemic solutions. </strong>To change the perspective across every node in a system is like aligning the stars in favour of a new constellation. It all kicks off when you find the stars that move most readily in the new direction. The Oxygen CoLab set out to solve a big market challenge and the CoLab participants most motivated to solve this challenge fuel everything we do.</p><p><strong>17. To involve one agent of change is to go fast, but to go far we must go together.</strong> COVIDaction quickly recognised that we’d get nowhere worthwhile alone, working with partners makes it possible to cover every piece of a complex puzzle.</p><p><strong>18. Innovation seems non-linear and yet incremental, it needs new ideas, which are often sparked by making useful connections. </strong>Designing the working practices to support oxygen concentrator innovation follows a similar path. Being a new initiative every collaborative interaction helps inform what we do in an incremental, non-linear way.</p><p><strong>19. Starting a CoLab means motivating others to join us. </strong>Being clear, simple, and curious first, makes the work we’re planning accessible. Being clever comes last. Joining in should be easy and enjoyable, we don’t want others to think too hard, they probably have enough on their plates already.</p><p><strong>20. Some problems seem like different pieces of a puzzle, to solve them you need a networked learning approach. </strong>The Oxygen CoLab seeks to stay in tune with one another’s work to spark useful connections amongst an active innovation space.</p><p>That’s a wrap! We hope that you have enjoyed our learnings and signals of possible futures, they will evolve and guide us through the future and maybe they can do the same for you.</p><p>We’ll keep on learning as our work continues and sharing the work that we do with amazing innovators in low and middle income countries around the world.</p><h3>Thank you for following our journey this year and we wish you a great start to 2021! 🥳</h3><p><em>Subscribe to our COVIDaction Friday Download </em><a href="https://covidaction.substack.com/"><em>newsletter</em></a><em> and follow us on </em><a href="https://twitter.com/COVIDactionTech"><em>Twitter</em></a><em> for more news on data, tech, news and links.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c07e123c1582" width="1" height="1" alt=""><hr><p><a href="https://medium.com/covidaction/20-things-we-learned-this-year-that-could-be-signals-of-what-comes-next-c07e123c1582">20 things we learned this year — that could be signals of what comes next</a> was originally published in <a href="https://medium.com/covidaction">COVIDaction</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Get your feet on the ground: insights from scouting local innovations]]></title>
            <link>https://medium.com/covidaction/get-your-feet-on-the-ground-insights-from-scouting-local-innovations-47ae7eb39f0f?source=rss-e221691e34b9------2</link>
            <guid isPermaLink="false">https://medium.com/p/47ae7eb39f0f</guid>
            <category><![CDATA[grassroots-innovation]]></category>
            <category><![CDATA[local-insights]]></category>
            <category><![CDATA[local-production]]></category>
            <dc:creator><![CDATA[Alex Losneanu]]></dc:creator>
            <pubDate>Fri, 11 Dec 2020 10:53:01 GMT</pubDate>
            <atom:updated>2020-12-11T10:55:31.371Z</atom:updated>
            <content:encoded><![CDATA[<h3>It’s now common to find innovation via the internet and often the search for solutions can fall into familiar patterns, following well-trodden paths. We decided that this process was ripe for change and so we went off that beaten track and worked with experienced local scouts to find innovation from offline communities in new places. We were amazed at what we found and proud to share our method and insights here.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/689/1*cwRs_kJjk5tR1_W0THf4Cw.png" /><figcaption>Local producer of hand sanitiser in Ghana</figcaption></figure><h3><strong>What we did</strong></h3><p>We set a goal to engage with offline communities in seven focus countries — Nigeria, Ghana, Cameroon, Uganda, Zambia, Kenya and South Sudan. COVIDaction and <a href="https://www.afrilabs.com/">AfriLabs</a> partnered to ensure that technical support and financial assistance got to the last mile and other hard to reach communities. Leveraging AfriLabs’ existing network of innovation hubs who have scouts with experience in identifying and supporting promising social enterprises, the organisations have collaborated to ensure we can expand our outreach to meet innovators across the continent and help them access opportunities they might not otherwise be aware of through conventional online channels.</p><h3><strong>What came back</strong></h3><p>The results of this work were more than we expected and really encouraging. We collected 79 applications across those seven countries, surfacing some remarkable responses to dealing with local demand for unavailable goods — including hand washing stations, sanitisers, and PPE products.</p><p>What is more — it helped to shift our perspective when it comes to reaching out for innovation. Working with the scouts helped us to shape a strategy for inclusiveness that breaks common grant cycles, uncovers new methodologies and brings out very different innovations for support.</p><p>If we had not changed this part of our methods, we would have missed out on some amazing innovators and local production at the grassroots level. Along with these fresh connections, we also learned more about what it means to create a successful call for innovators that are not connected to the internet.</p><p>The hard work of extracting these offline innovations was not in vain. Our assessment process showed that they were of high quality and relevant to our cause. Our expert judges assessed all applications (online and offline) using the same judging criteria. The judging results showed that: 1) the average scores between the two categories were the same and 2) that 2 out of 3 of the top scoring innovations were from the offline call.</p><h3><strong>Here are 5 things we’ve learned</strong></h3><h4><strong>1. Having feet on the ground is crucial</strong></h4><p>Working with local scouts to meet innovators face to face was critical for success as it meant that we were able to leverage their experience. These experts are familiar with target locations, speak the local dialect, understand the culture, are able to create a sense of trust with grantees and have experience engaging with the local producers there. The intricacies from the daily experiences and struggles of offline innovators would not have been captured through traditional online channels.</p><p>Being able to work like this with experts meant that in our LPLS calls we were able to map out different countries, better understand how active their local production ecosystems are and spot areas of interest.</p><h4><strong>2. Communication barriers are a reality</strong></h4><p>Put plainly — our call was in English and some local innovators spoke other languages. Local interpretations of concepts or technical terms might also be different. It is important that there is a way to translate and communicate well with offline innovators.</p><p>It is important to engage local scouts who understand the local dialect of the target location and data collection instruments need to be as concise as possible so that respondents clearly understand the questions and the responses they are being asked to provide. That way, they’ll fully understand what data is required from them and how the data is used. We gave scouts the agency to make any changes to the submission forms that they considered necessary for this to happen.</p><p>Furthermore, our call required applicants to interpret technical concepts and questions. The way in which these technical terms are understood is crucial as it forms part of our assessment process. The scouts played an important role in translating and explaining these technicalities to offline innovators so that the true value of their production or solution could be extracted.</p><h4><strong>3. It’s almost impossible to work with local innovators if there is no trust in the working relationship</strong></h4><p>This issue turned up in a number of ways — some innovators are reluctant to share data or ideas as they are rightly concerned about IP theft; some had not had any support at all in the past and they were wary of offers as no one had been able to reach out to them in the past.</p><p>Communication is a big part of the solution here. Scouts reported that offline innovators believed that stakeholders were only approaching them to get their data and would never be informed of future opportunities. The best way we found of resolving this issue is to get in touch when a real opportunity is available. This way, we can build confidence and encourage more participation with different communities in future.</p><h4><strong>4. Scouts need to be empowered and enabled</strong></h4><p>Offline scouting comes with its challenges. Access to remote locations, rejection of scouts by respondents, doubts about the reality of some opportunities and more. Scouts need to be prepared to face these challenges and prepare their own contingency plans to navigate them.</p><p>Giving scouts the freedom and agency to work in the environments where they are experts means they are able to get work done freely without added restrictions from an outside source. Making this clear and negotiating this early in the process makes life and work easier for everyone.</p><h4><strong>5. Offers need to be tailored</strong></h4><p>The offline scouts let us know about several capacity gaps and key needs in their territories. Producers were calling for capacity building strategies, support with resources and access to markets to scale their innovations and businesses. They’re also looking forward to more opportunities reaching them.</p><p>This pointed to an important core element of development support. Though finance is fine and cash is crucial, innovators are also keen to connect with technical assistance and networking opportunities. This is what will bring communities together.</p><h4>We hope that some of our learnings will be useful to others. By embracing inclusiveness across our scouting techniques, we believe we created a true “open call” and one that is bound to evolve as we continue our work. In a world where everything seems so highly connected, and conversations can take place in real time around the world it may seem that the internet is the only way to find innovation. This is clearly not the case.</h4><p>There are great people doing incredible work offline. If we go that extra mile to meet them, support them and learn from them, everyone benefits and while we are still working under the pressures of a pandemic, there’s no better time to reach out and find those connections. To find out how scouts work in their own words, meet <a href="https://medium.com/covidaction/what-offline-innovation-can-teach-us-during-the-pandemic-660bcc174fc0">Lusanda Maguape</a> and <a href="https://medium.com/covidaction/afrilabs-scouts-engage-grassroots-communities-for-impact-in-africa-e5472bb96e70">Osasenaga Enogieru</a> who shared their personal observations with us.</p><p><em>Hungry for more? To avoid missing our updates subscribe to our COVIDaction </em><a href="https://covidaction.substack.com/"><em>newsletter</em></a><em> and follow us on </em><a href="https://twitter.com/COVIDactionTech"><em>Twitter</em></a><em> for more news on data, tech, news and links.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=47ae7eb39f0f" width="1" height="1" alt=""><hr><p><a href="https://medium.com/covidaction/get-your-feet-on-the-ground-insights-from-scouting-local-innovations-47ae7eb39f0f">Get your feet on the ground: insights from scouting local innovations</a> was originally published in <a href="https://medium.com/covidaction">COVIDaction</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Exploring the future of frontier technologies for development in India]]></title>
            <link>https://medium.com/frontier-technologies-hub/exploring-the-future-of-frontier-technologies-for-development-in-india-586b1d4e0925?source=rss-e221691e34b9------2</link>
            <guid isPermaLink="false">https://medium.com/p/586b1d4e0925</guid>
            <category><![CDATA[international-development]]></category>
            <category><![CDATA[innovation]]></category>
            <category><![CDATA[technology]]></category>
            <category><![CDATA[frontier-tech]]></category>
            <category><![CDATA[future]]></category>
            <dc:creator><![CDATA[Alex Losneanu]]></dc:creator>
            <pubDate>Fri, 21 Feb 2020 17:37:35 GMT</pubDate>
            <atom:updated>2020-02-21T17:37:35.401Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*4m3Ce4ZODFtez5C09ZpzYQ.jpeg" /></figure><blockquote>What are the frontier technologies showing the most promise in international development?</blockquote><blockquote>How might technology affect our work, and what should I be doing about it?</blockquote><blockquote>What are the potential impacts — positive and negative, intended and unintended — of future tech and how can we leave no-one behind even as we make progress at pace?</blockquote><p><a href="https://medium.com/frontier-technology-livestreaming/futures/home">Frontier Tech Futures</a> is an immersive experience designed to enable DFID country offices and departments to answer questions like these. In December, the Futures programme went to India and through a week-long programme in-country, DFID India teams, partners and stakeholders had the opportunity to connect with what’s next in technology. We met and heard from local technologists on tech as diverse as: IoT, Big Data, drones, AI &amp; ML, blockchain, and learned about the implications of using frontier tech in programme management. We also collaborated on core programmatic areas of work (i.e. Urban, Climate Resilience, Enterprise &amp; Finance), exploring the frontier technologies showing the highest impact potential and challenges faced when scaling solutions.</p><p>During our time together, key questions emerged like:</p><h4><strong>How can India close its digital divide and make tech more accessible?</strong></h4><p>India is going through a major digital transformation, underpinned by the <a href="https://indiastack.org/about/">India Stack</a> government project. The vision is to provide the right digital infrastructure and open APIs to be leveraged by developers and tech start-ups to build inclusive digital services. This is easier said than done — as well many successes, early projects have had their <a href="https://qz.com/india/1399518/whatever-indias-supreme-court-says-aadhaar-was-never-a-photo-id/">share of failures</a>, and despite all the recent developments and efforts, the large low-and-middle income (LMI) segment still remains underserved.</p><p>Digital inclusion by design is still uncommon, therefore many initiatives end up being retrofitted to serve the LMI segment with very limited scale. However, there is a strong drive to address this issue in India, particularly at a grassroots level. During Futures Week India we heard from key players in the tech ecosystem about promising initiatives like the <a href="https://www.microsave.net/signature-projects/channelize-usd-9-5m-to-transform-fintech-start-ups/">Financial Inclusion Lab</a> that supports start-ups with a specific focus on LMIs, and <a href="https://www.outlineindia.com/">Outline India</a>’s approach to scaling digital inclusion initiatives by enabling the local enablers. Ultimately context is everything — what works in one place may not in another, which is why experimentation and trial and error is key to unlocking this segment.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*K96Zyui65X-SqjKW" /></figure><h4><strong>How can DFID India accelerate getting promising innovations to scale?</strong></h4><blockquote>“The bane of urban development are pilots that don’t make it to scale”</blockquote><p>This was just one of the catchphrases of the week that stayed with us. Too often, development solutions struggle to scale. Throughout the week we’ve heard about the difficulty of solving India’s key challenges without addressing the system that creates the problem in the first place — tech can be a catalyst, but it may not succeed on its own. How might the journey from short-term improvements to fixing a broken system to enable scale look like? Any answer is somewhat subjective, but what was clear from the Futures sessions is that India’s most complex challenges (such as urban development) require a bold vision, with humble actions to test and learn along the way, and a mix of point-solutions AND system innovations. Big problems can’t be solved by one organisation or sector alone. A networked approach of connecting at a grassroots level is needed, as well as establishing partnerships with private sector players and framing mutual benefits to bring them onboard. Through the <a href="https://millionneighborhoods.org/#2/3.96/16.77">Million Neighbourhoods</a> project, we also learnt about the importance of mapping the scale of problems, which is essential to bring players on the same page and effect the required exponential change.</p><h4><strong>We need tech to be ethical and environmentally sustainable. What’s DFID’s role to support India with these challenges?</strong></h4><p>With the abundance of tech talent and innovations coming from India, the question of ethics and unintended consequences of technology is one still to be addressed. Innovation usually starts before regulation, as we’re seeing in many cases including in the ‘future of mobility’ space. To combat pollution (India is battling with air pollution that is amongst the most severe in the world), the government has decreed that all vehicles sales be electric by 2030, and is starting to establish supporting guidelines and regulations for EVs. However, other emerging ‘future mobility’ initiatives, such as shared mobility/carpooling, that are mainly driven by start-ups (see <a href="https://sride.co/">sRide</a>) have received less attention, but need ethics frameworks to enable safe services and uptake. There is an opportunity to close the gap around the policy narrative on ethics to future-proof innovation in India. Tools and organisations already exist to guide this conversation — such as <a href="https://theodi.org/article/data-ethics-canvas/">The ODI’s Data Ethics Canvas</a> and the <a href="https://www.gov.uk/government/organisations/centre-for-data-ethics-and-innovation">Centre for Data Ethics and Innovation</a>, which provides recommendations to the UK Government, that is required to respond to within a set number of weeks. Would an independent body for technology ethics in India help deepen accountability and transparency?</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*zF2gou-skiLEjITN" /></figure><h4><strong>How can we ensure we design the right thing, then design the thing right?</strong></h4><p>The quality and impact of our solutions depends on the correct framing of the problem. Throughout the week we heard reminders to always start with understanding what the end user truly needs, before asking how technology might help. Ultimately, technology is just one of the components of a solution. One of the main goals of the Frontier Technology Futures Weeks is to demystify technologies, but we also introduced innovation tools (such as the <a href="https://drive.google.com/open?id=19W4aMxIWEhtzs7-OXAkKfotvxN4PNYdf">Service Blueprint</a>) through short ‘Daily Innovation Workout’ sessions to enable service designers to have a more user-led approach to innovation. We’ve decided to frame the relationship between innovation &amp; technology (too often used interchangeably) even more in our following Futures Weeks and bake this in all key sessions.</p><p>Our next stop: Futures Week Rwanda — so watch this space!</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=586b1d4e0925" width="1" height="1" alt=""><hr><p><a href="https://medium.com/frontier-technologies-hub/exploring-the-future-of-frontier-technologies-for-development-in-india-586b1d4e0925">Exploring the future of frontier technologies for development in India</a> was originally published in <a href="https://medium.com/frontier-technologies-hub">Frontier Tech Hub</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>